This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chong Kun Dang Pharmaceutical Corporation, National Cancer Center. Active years: 2018.
Company Filing History:
1 out of 52 
1 out of 263 
Years Active: 2018
Title: MinChae Kim: Innovator in Cancer Treatment
Introduction
MinChae Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative approach combines various compounds to enhance therapeutic efficacy against cancer.
Latest Patents
MinChae Kim holds a patent for a combined composition aimed at preventing or treating cancer. The patent, titled "Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitor," describes a pharmaceutical composition that includes a compound of formula 1 or a pharmaceutically acceptable salt thereof, along with a topoisomerase inhibitor. This composition specifically inhibits cell proliferation and induces apoptosis in various cancers, including colorectal and ovarian cancer. The unique mechanism of action allows it to be effective against tumors that are resistant to traditional vascular disrupting agents.
Career Highlights
Throughout his career, MinChae Kim has worked with notable organizations such as Chong Kun Dang Pharmaceutical Corporation and the National Cancer Center. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
MinChae Kim has collaborated with several professionals in his field, including Soo Jin Kim and Young Sang Kim. These collaborations have contributed to the advancement of his research and the development of effective cancer therapies.
Conclusion
MinChae Kim's work in developing a combined composition for cancer treatment showcases his dedication to improving patient outcomes. His innovative contributions to the pharmaceutical industry highlight the importance of research and collaboration in the fight against cancer.